Drug Trial Radar · NCT04123626
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
Last checked: Nov 20, 2026Latest source record: May 6, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
11
Actual
Start
Oct 7, 2019
Primary completion
Jun 7, 2022
Study completion Jun 7, 2022
Sponsor
- Lead sponsor
- ProQR TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Oct 11, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the safety, tolerability and efficacy of QR-1123 injection in the eye (intravitreal; IVT) injections (one eye/unilateral) in subjects receiving a single dose or repeat doses. Single injections will be assessed in an open label way, and repeat injections will be assessed in a double-masked, randomized, sham-controlled fashion.
Conditions
- Autosomal Dominant Retinitis Pigmentosa
- Eye Diseases
- Eye Diseases, Hereditary
- Retinal Dystrophies
- Retinal Disease
- Retinitis
- Vision Tunnel
- Vision Disorders
Interventions
QR-1123Drug
unilateral IVT injection
Sham procedureOther
Sham procedures (i.e. no penetration of the globe) closely mimic the active injection and serve to mask subjects to treatment assignment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and Severity of ocular AEsTime frame: up to 12 months
- Incidence and Severity of non-ocular AEsTime frame: up to 12 months
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Sue Anschutz-Rogers Eye Center, University of Colorado - Dept. of Ophthalmology
Aurora, Colorado
VitreoRetinal Associates
Gainesville, Florida
Shriners UK Ophthalmology - University of Kentucky
Lexington, Kentucky
Casey Eye Institute, OHSU
Portland, Oregon
Retina Foundation of the Southwest
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.